Extends penalties for driving under the influence to include any substance that impairs driving ability; deems driver's consent to non-invasive drug tests.
Impact
Under this bill, individuals who operate vehicles while impaired by drugs (both illegal and legal) will face penalties analogous to those for alcohol-related offenses. The law will also conclude that any motorist operating a vehicle is presumed to have consented to evaluations by certified drug recognition experts if approached by law enforcement. These experts will help determine whether the individual is impaired by substances, expanding the law enforcement's toolkit for handling impaired drivers. Moreover, the bill stipulates penalties for refusing such evaluations, aligning them with those for refusing blood alcohol content tests.
Summary
Bill A2786 proposes significant amendments to New Jersey's existing drunk driving statute, specifically R.S.39:4-50. The bill extends penalties for driving under the influence to include not just alcohol but any substance or combination of substances that can impair a person's ability to operate a motor vehicle. This existing law applies predominantly to narcotic and hallucinogenic drugs, so the bill broadens the scope substantially, aiming to address the rising concerns over impaired driving due to a variety of legal and illegal substances.
Contention
Opponents of the bill may raise concerns over the implications for personal rights and the potential for misuse in its enforcement. Critics may argue that the broad definition of impairing substances can lead to arbitrary enforcement and disproportionate penalties for individuals who may use legally prescribed medications. Supporters, on the other hand, assert that the new measures are crucial to improving road safety and reducing accidents caused by impaired driving, framing the legislation as a necessary evolution to adapt to current challenges relating to substance use.
Carry Over
Extends penalties for driving under the influence to include any substance that impairs driving ability; deems driver's consent to non-invasive drug tests.